Targeted prodrug approaches for hormone refractory prostate cancer.
about
MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.Improving the Specificity of the Prostate-Specific Antigen Substrate Glutaryl-Hyp-Ala-Ser-Chg-Gln as a Promoiety.
P2860
Targeted prodrug approaches for hormone refractory prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeted prodrug approaches for hormone refractory prostate cancer.
@en
type
label
Targeted prodrug approaches for hormone refractory prostate cancer.
@en
prefLabel
Targeted prodrug approaches for hormone refractory prostate cancer.
@en
P2860
P356
P1476
Targeted prodrug approaches for hormone refractory prostate cancer
@en
P2093
Herve Aloysius
P2860
P304
P356
10.1002/MED.21333
P50
P577
2014-12-22T00:00:00Z